Review Pathogens · 2025 Role of Uropathogenic Escherichia coli and Other Pathogens in Kidney Stone Formation: From Pathogenesis to Treatment. Zalewska-Piątek B, Nagórka M, Piątek R Escherichia coli PubMed ↗
Clinical trial Science · 2025 Controlled colonization of the human gut with a genetically engineered microbial therapeutic. Whitaker WR, Russ ZN, Stanley Shepherd E, et al. Phocaeicola vulgatus PubMed ↗
Review Frontiers in cellular and infection microbiology · 2025 How is the human microbiome linked to kidney stones? Pei X, Liu M, Yu S Bifidobacterium bifidum PubMed ↗
Clinical trial Urologia · 2024 Oral supplementation with probiotics, potassium citrate, and magnesium in reducing crystalluria in stone formers: A phase II study. Vittori M, Bove P, Signoretti M, et al. Bifidobacterium breve PubMed ↗
Meta-analysis BMC microbiology · 2023 Gut microbiota in patients with kidney stones: a systematic review and meta-analysis. Yuan T, Xia Y, Li B, et al. Escherichia coli PubMed ↗
Randomized trial Urology journal · 2021 Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial. Tavasoli S, Jalali S, Naji M, et al. Bifidobacterium animalis PubMed ↗
Microbiome · 2025 Dysbiosis of the gut microbiota in calcium oxalate nephrolithiasis is associated with impaired short-chain fatty acid production and systemic metabolomic disruptions. Chen X, Zhang F, Cheng L, et al. Agathobacter rectalisBacteroides thetaiotaomicronFaecalibacterium prausnitzii PubMed ↗
Nature communications · 2024 Cefazolin shifts the kidney microbiota to promote a lithogenic environment. Agudelo J, Chen X, Mukherjee SD, et al. Escherichia coli PubMed ↗
Urolithiasis · 2024 Species-level characterization of gut microbiota and their metabolic role in kidney stone formation using full-length 16S rRNA sequencing. Hussain B, Wu CC, Tsai HC, et al. Akkermansia muciniphilaPhocaeicola plebeiusPhocaeicola vulgatus PubMed ↗
Urolithiasis · 2024 Deficient butyrate metabolism in the intestinal microbiome is a potential risk factor for recurrent kidney stone disease. Choy WH, Adler A, Morgan-Lang C, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Journal of pediatric urology · 2023 The intestinal microbiome of children with initial and recurrent nephrolithiasis: A pilot study and exploratory analysis. Ellison JS, Atkinson SN, Hayward M, et al. [Eubacterium] siraeum PubMed ↗
Nutrients · 2021 Influence of Short-Term Consumption of Hericium erinaceus on Serum Biochemical Markers and the Changes of the Gut Microbiota: A Pilot Study. Xie XQ, Geng Y, Guan Q, et al. Agathobacter rectalisBacteroides caccaeFaecalibacterium prausnitziiFusicatenibacter saccharivorans +3 more PubMed ↗
Animal study BMC microbiology · 2025 A novel synbiotic formulation prevents calcium oxalate stones by restoring gut microbiota homeostasis. Li XM, Amier Y, Wan WL, et al. Bifidobacterium breve PubMed ↗
Animal study Clinical laboratory · 2023 Potential Role of Lactobacillus and Bifidobacterium for Preventing Kidney Stones. Masoleh AM, Khoshnood S, Haddadi MH, et al. Bifidobacterium longum PubMed ↗
Animal study International urology and nephrology · 2022 Vinegar reduced renal calcium oxalate stones by regulating acetate metabolism in gut microbiota and crystal adhesion in rats. Liu Y, Jin X, Ma Y, et al. [Ruminococcus] torques PubMed ↗